Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2015

Feb 11, 2015

30786_dirs_2015-02-10_71a74dc7-15f6-4746-a09a-6d75329e9877.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2015-02-09

Reporting Person: SCHWARTZ NORMAN D (Director, Chairman, President, and CEO, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-02-09 Bio-Rad B Common Stock M 75628 $56.40 Acquired 228108 Direct
2015-02-09 Bio-Rad B Common Stock F 55602 $117.35 Disposed 172506 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-02-09 Non-Qualified Stock Option (right to buy) $56.40 M 75628 Disposed 2015-02-09 Bio-Rad B Common Stock (75628) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Bio-Rad A Common Stock 411252 Direct
Bio-Rad B Common Stock 12486 Indirect
Bio-Rad B Common Stock 4060054 Indirect
Bio-Rad B Common Stock 13726 Indirect

Footnotes

F1: The reporting person disclaims beneficial ownership of these shares.

F2: The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

F3: The shares are held by a limited partnership of which the reporting person is a limited partner.

F4: The option vested in five equal annual installments beginning on February 9, 2006.